Clinical Trial Update: High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose methotrexate with leucovorin in newly diagnosed glioblastoma multiforme (brain and CNS tumors).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Leucovorin (folinic acid)
• Methotrexate (high-dose) (Methotrexate)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED